Peripherally Inserted Central Catheters Market Analysis

Peripherally Inserted Central Catheters Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is categorized into power injected PICC, conventional PICC, and neonatal PICC. The power injected PICC segment dominated the market and was valued at USD 599.2 million in revenue in 2023.

• Power injected PICCs are specifically designed to withstand higher injection pressures, making them suitable for delivering contrast media or medications at rapid infusion rates. This feature is particularly beneficial in diagnostic imaging procedures such as computed tomography (CT) scans, where high-pressure injections are required for optimal imaging.

   

• Additionally, power-injected PICCs feature larger lumens and more robust construction, facilitating higher flow rates during infusion. This enables faster administration of fluids and medications, enhancing efficiency and patient throughput in clinical settings, thereby increasing their demand in the market.

   

Based on lumen, the peripherally inserted central catheters market is categorized into single, double, and multiple. The double lumen segment dominated the market, with the revenue of around USD 632.3 million in revenue in 2023.

• Double lumen catheters offer the versatility of having two lumens within a single catheter, allowing for simultaneous administration of multiple medications or fluids. This feature is particularly advantageous in critical care settings where patients may require different therapies concurrently.

   

• Additionally, using a double lumen catheter instead of other lumen types can be more cost-effective, as it eliminates the need for additional catheter kits, insertion procedures, and maintenance. This is particularly important in healthcare systems aiming to optimize resources and reduce healthcare costs, hence, contributes to its increasing demand.

   

Based on application, the peripherally inserted central catheters market is categorized into chemotherapy, long-term IV infusion, parenteral nutrition, blood transfusion, and other applications. The long-term IV infusion segment dominated the market, with the revenue of around USD 426.4 million in revenue in 2023.

• Long-term IV infusion refers to the administration of fluids, medications, or therapies over an extended period, typically more than a week. This application encompasses a wide range of treatments, including antibiotics, pain management, hydration, and chemotherapy, among others. As a result, it serves a broad patient population with diverse medical needs.

   

• Additionally, many patients with chronic conditions require ongoing IV therapy to manage their health. Long-term IV infusion provides a convenient and effective way to administer medications or nutrients over an extended period, allowing patients to receive treatment without frequent hospital visits, may contributes to its increasing demand for this application.

Based on end-use, the peripherally inserted central catheters market is categorized into hospitals, ambulatory surgical centers, home-care centers, and other end-users. The hospitals are segment held the dominant position in the market and is anticipated to reach around USD 1.2 billion in 2032.

• Hospitals have the infrastructure, resources, and specialized medical staff to manage patients with serious medical conditions. PICC insertion and management often require skilled healthcare professionals, making hospitals the preferred setting for these procedures.

   

• Moreover, hospital environments provide continuous monitoring and support for patients with PICCs, ensuring proper placement, function, and management of the catheters. This level of monitoring is essential for preventing complications such as infection, thrombosis, or catheter dislodgement, thereby increasing their necessity in healthcare settings such as hospitals.

North America peripherally inserted central catheters market accounted for USD 447 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• North America has a well-developed healthcare infrastructure with advanced hospitals, clinics, and ambulatory surgical centers. These facilities have the expertise and resources to support the insertion, management, and care of PICCs, contributing to their widespread use.

   

• Additionally, favorable reimbursement policies for PICC procedures and related services in North America incentivize healthcare providers to use PICCs for appropriate patients. Reimbursement coverage for PICC-related expenses ensures that patients have access to this essential vascular access device.

   

U.S. peripherally inserted central catheters market holds a dominant position with the market share of 92.5% in 2023.

• There is a growing trend towards home-based healthcare in the U.S., driven by factors such as an aging population, healthcare cost containment, and patient preference. PICCs allow patients to receive long-term IV therapy at home, providing convenience and improving their quality of life.

   

• Additionally, according to a report by the Centers for Medicare & Medicaid Services (CMS) published in 2021, the demand for home healthcare services in the U.S. has been steadily increasing. The report indicated that the number of Medicare beneficiaries receiving home healthcare services grew by 27% from 3.5 million in 2000 to 4.5 million in 2018. This trend reflects the growing preference among patients for receiving healthcare services in the comfort of their own homes, including treatments that may require peripherally inserted central catheters (PICCs) for long-term intravenous therapy.

   

Germany peripherally inserted central catheters market is anticipated to witness notable growth during 2024-2032.

• Germany, like many other developed countries, has an aging population with a high prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes. These conditions often require long-term intravenous therapy, driving the demand for PICCs as a reliable vascular access option.

   

• Additionally, aging demographic in Germany contributes to the rising incidence of chronic diseases, further fueling the demand for peripherally inserted central catheters (PICCs) as a preferred vascular access option for long-term intravenous therapy.

   

China may experience a high growth potential in the peripherally inserted central catheters market.

• There is growing awareness among healthcare professionals and patients about the benefits of PICCs for long-term intravenous therapy. As a result, PICCs are increasingly being recognized as a preferred option for vascular access in China's healthcare system.

   

• Additionally, Chinese government's focus on improving healthcare infrastructure and promoting the adoption of advanced medical devices has also contributed to the rising acceptance of PICCs among healthcare providers and patients.